APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydrolyzed Collagen Peptides

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hydrolyzed Collagen Peptides Market Outlook and Growth Opportunities 2026

7 January 2026203 pages

Choose your research edition.

Industry ResearchHydrolyzed Collagen Peptides Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydrolyzed Collagen Peptides Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Hydrolyzed Collagen Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydrolyzed Collagen Peptides Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydrolyzed Collagen Peptides Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Hydrolyzed Collagen Peptides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hydrolyzed Collagen Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydrolyzed Collagen Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydrolyzed Collagen Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hydrolyzed Collagen Peptides market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hydrolyzed Collagen Peptides market include Rousselot, Gelita, PB Gelatins, Nitta, Weishardt, Neocell, BHN, NIPPI and Beyond Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydrolyzed Collagen Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydrolyzed Collagen Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydrolyzed Collagen Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydrolyzed Collagen Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydrolyzed Collagen Peptides Segment by Company

Rousselot

Gelita

PB Gelatins

Nitta

Weishardt

Neocell

BHN

NIPPI

Beyond Biopharma

Cosen Biochemical

Taiaitai

SEMNL Biotechnology

HDJR

HaiJianTang

Dongbao

Huayan Collagen

Mingrang

Hailisheng

Oriental Ocean

CSI BioTech

Hydrolyzed Collagen Peptides Segment by Type

Bone

Bovine Hide

Fish

Pig Skin

Others

Hydrolyzed Collagen Peptides Segment by Application

Food and Beverages

Pharmaceutical

Cosmetics

Personal Care

Pet Food

Others

Hydrolyzed Collagen Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hydrolyzed Collagen Peptides status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hydrolyzed Collagen Peptides market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hydrolyzed Collagen Peptides significant trends, drivers, influence factors in global and regions.

6. To analyze Hydrolyzed Collagen Peptides competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrolyzed Collagen Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydrolyzed Collagen Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrolyzed Collagen Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydrolyzed Collagen Peptides market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hydrolyzed Collagen Peptides industry.

Chapter 3: Detailed analysis of Hydrolyzed Collagen Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hydrolyzed Collagen Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hydrolyzed Collagen Peptides in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hydrolyzed Collagen Peptides Industry Trends Table 2. Hydrolyzed Collagen Peptides Industry Drivers Table 3. Hydrolyzed Collagen Peptides Industry Opportunities and Challenges Table 4. Hydrolyzed Collagen Peptides Industry Restraints Table 5. Global Hydrolyzed Collagen Peptides Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hydrolyzed Collagen Peptides Revenue Share by Company (2021-2026) Table 7. Global Hydrolyzed Collagen Peptides Sales Volume by Company (t) & (2021-2026) Table 8. Global Hydrolyzed Collagen Peptides Sales Volume Share by Company (2021-2026) Table 9. Global Hydrolyzed Collagen Peptides Average Price (USD/t) of Company (2021-2026) Table 10. Global Hydrolyzed Collagen Peptides Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hydrolyzed Collagen Peptides Key Company Manufacturing Base & Headquarters Table 12. Global Hydrolyzed Collagen Peptides Company, Product Type & Application Table 13. Global Hydrolyzed Collagen Peptides Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydrolyzed Collagen Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bone Table 18. Significant Companies of Bovine Hide Table 19. Significant Companies of Fish Table 20. Significant Companies of Pig Skin Table 21. Significant Companies of Others Table 22. Global Hydrolyzed Collagen Peptides Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 23. Global Hydrolyzed Collagen Peptides Sales Volume by Type (2021-2026) & (t) Table 24. Global Hydrolyzed Collagen Peptides Sales Volume by Type (2027-2032) & (t) Table 25. Global Hydrolyzed Collagen Peptides Sales Volume Share by Type (2021-2026) Table 26. Global Hydrolyzed Collagen Peptides Sales Volume Share by Type (2027-2032) Table 27. Global Hydrolyzed Collagen Peptides Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Hydrolyzed Collagen Peptides Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Hydrolyzed Collagen Peptides Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Hydrolyzed Collagen Peptides Sales Value Share by Type (2021-2026) Table 31. Global Hydrolyzed Collagen Peptides Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Food and Beverages Table 33. Significant Companies of Pharmaceutical Table 34. Significant Companies of Cosmetics Table 35. Significant Companies of Personal Care Table 36. Significant Companies of Pet Food Table 37. Significant Companies of Others Table 38. Global Hydrolyzed Collagen Peptides Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 39. Global Hydrolyzed Collagen Peptides Sales Volume by Application (2021-2026) & (t) Table 40. Global Hydrolyzed Collagen Peptides Sales Volume by Application (2027-2032) & (t) Table 41. Global Hydrolyzed Collagen Peptides Sales Volume Share by Application (2021-2026) Table 42. Global Hydrolyzed Collagen Peptides Sales Volume Share by Application (2027-2032) Table 43. Global Hydrolyzed Collagen Peptides Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Hydrolyzed Collagen Peptides Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Hydrolyzed Collagen Peptides Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Hydrolyzed Collagen Peptides Sales Value Share by Application (2021-2026) Table 47. Global Hydrolyzed Collagen Peptides Sales Value Share by Application (2027-2032) Table 48. Global Hydrolyzed Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032 (t) Table 49. Global Hydrolyzed Collagen Peptides Sales by Region (2021-2026) & (t) Table 50. Global Hydrolyzed Collagen Peptides Sales Market Share by Region (2021-2026) Table 51. Global Hydrolyzed Collagen Peptides Sales by Region (2027-2032) & (t) Table 52. Global Hydrolyzed Collagen Peptides Sales Market Share by Region (2027-2032) Table 53. Global Hydrolyzed Collagen Peptides Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Hydrolyzed Collagen Peptides Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Hydrolyzed Collagen Peptides Sales Value Share by Region (2021-2026) Table 56. Global Hydrolyzed Collagen Peptides Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Hydrolyzed Collagen Peptides Sales Value Share by Region (2027-2032) Table 58. Global Hydrolyzed Collagen Peptides Market Average Price (USD/t) by Region (2021-2026) Table 59. Global Hydrolyzed Collagen Peptides Market Average Price (USD/t) by Region (2027-2032) Table 60. Global Hydrolyzed Collagen Peptides Sales by Country: 2021 VS 2025 VS 2032 (t) Table 61. Global Hydrolyzed Collagen Peptides Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Hydrolyzed Collagen Peptides Sales by Country (2021-2026) & (t) Table 63. Global Hydrolyzed Collagen Peptides Sales Market Share by Country (2021-2026) Table 64. Global Hydrolyzed Collagen Peptides Sales by Country (2027-2032) & (t) Table 65. Global Hydrolyzed Collagen Peptides Sales Market Share by Country (2027-2032) Table 66. Global Hydrolyzed Collagen Peptides Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Hydrolyzed Collagen Peptides Sales Value Market Share by Country (2021-2026) Table 68. Global Hydrolyzed Collagen Peptides Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Hydrolyzed Collagen Peptides Sales Value Market Share by Country (2027-2032) Table 70. Rousselot Company Information Table 71. Rousselot Business Overview Table 72. Rousselot Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Rousselot Hydrolyzed Collagen Peptides Product Portfolio Table 74. Rousselot Recent Development Table 75. Gelita Company Information Table 76. Gelita Business Overview Table 77. Gelita Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Gelita Hydrolyzed Collagen Peptides Product Portfolio Table 79. Gelita Recent Development Table 80. PB Gelatins Company Information Table 81. PB Gelatins Business Overview Table 82. PB Gelatins Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. PB Gelatins Hydrolyzed Collagen Peptides Product Portfolio Table 84. PB Gelatins Recent Development Table 85. Nitta Company Information Table 86. Nitta Business Overview Table 87. Nitta Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Nitta Hydrolyzed Collagen Peptides Product Portfolio Table 89. Nitta Recent Development Table 90. Weishardt Company Information Table 91. Weishardt Business Overview Table 92. Weishardt Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Weishardt Hydrolyzed Collagen Peptides Product Portfolio Table 94. Weishardt Recent Development Table 95. Neocell Company Information Table 96. Neocell Business Overview Table 97. Neocell Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Neocell Hydrolyzed Collagen Peptides Product Portfolio Table 99. Neocell Recent Development Table 100. BHN Company Information Table 101. BHN Business Overview Table 102. BHN Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. BHN Hydrolyzed Collagen Peptides Product Portfolio Table 104. BHN Recent Development Table 105. NIPPI Company Information Table 106. NIPPI Business Overview Table 107. NIPPI Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. NIPPI Hydrolyzed Collagen Peptides Product Portfolio Table 109. NIPPI Recent Development Table 110. Beyond Biopharma Company Information Table 111. Beyond Biopharma Business Overview Table 112. Beyond Biopharma Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Beyond Biopharma Hydrolyzed Collagen Peptides Product Portfolio Table 114. Beyond Biopharma Recent Development Table 115. Cosen Biochemical Company Information Table 116. Cosen Biochemical Business Overview Table 117. Cosen Biochemical Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Cosen Biochemical Hydrolyzed Collagen Peptides Product Portfolio Table 119. Cosen Biochemical Recent Development Table 120. Taiaitai Company Information Table 121. Taiaitai Business Overview Table 122. Taiaitai Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Taiaitai Hydrolyzed Collagen Peptides Product Portfolio Table 124. Taiaitai Recent Development Table 125. SEMNL Biotechnology Company Information Table 126. SEMNL Biotechnology Business Overview Table 127. SEMNL Biotechnology Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. SEMNL Biotechnology Hydrolyzed Collagen Peptides Product Portfolio Table 129. SEMNL Biotechnology Recent Development Table 130. HDJR Company Information Table 131. HDJR Business Overview Table 132. HDJR Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 133. HDJR Hydrolyzed Collagen Peptides Product Portfolio Table 134. HDJR Recent Development Table 135. HaiJianTang Company Information Table 136. HaiJianTang Business Overview Table 137. HaiJianTang Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 138. HaiJianTang Hydrolyzed Collagen Peptides Product Portfolio Table 139. HaiJianTang Recent Development Table 140. Dongbao Company Information Table 141. Dongbao Business Overview Table 142. Dongbao Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 143. Dongbao Hydrolyzed Collagen Peptides Product Portfolio Table 144. Dongbao Recent Development Table 145. Huayan Collagen Company Information Table 146. Huayan Collagen Business Overview Table 147. Huayan Collagen Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 148. Huayan Collagen Hydrolyzed Collagen Peptides Product Portfolio Table 149. Huayan Collagen Recent Development Table 150. Mingrang Company Information Table 151. Mingrang Business Overview Table 152. Mingrang Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 153. Mingrang Hydrolyzed Collagen Peptides Product Portfolio Table 154. Mingrang Recent Development Table 155. Hailisheng Company Information Table 156. Hailisheng Business Overview Table 157. Hailisheng Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 158. Hailisheng Hydrolyzed Collagen Peptides Product Portfolio Table 159. Hailisheng Recent Development Table 160. Oriental Ocean Company Information Table 161. Oriental Ocean Business Overview Table 162. Oriental Ocean Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 163. Oriental Ocean Hydrolyzed Collagen Peptides Product Portfolio Table 164. Oriental Ocean Recent Development Table 165. CSI BioTech Company Information Table 166. CSI BioTech Business Overview Table 167. CSI BioTech Hydrolyzed Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 168. CSI BioTech Hydrolyzed Collagen Peptides Product Portfolio Table 169. CSI BioTech Recent Development Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Hydrolyzed Collagen Peptides Distributors List Table 173. Hydrolyzed Collagen Peptides Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Hydrolyzed Collagen Peptides Product Image Figure 2. Global Hydrolyzed Collagen Peptides Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydrolyzed Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hydrolyzed Collagen Peptides Sales (2021-2032) & (t) Figure 5. Global Hydrolyzed Collagen Peptides Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Hydrolyzed Collagen Peptides Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bone Image Figure 10. Bovine Hide Image Figure 11. Fish Image Figure 12. Pig Skin Image Figure 13. Others Image Figure 14. Global Hydrolyzed Collagen Peptides Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Hydrolyzed Collagen Peptides Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Hydrolyzed Collagen Peptides Sales Volume Share by Type (2021-2032) Figure 17. Global Hydrolyzed Collagen Peptides Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Hydrolyzed Collagen Peptides Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Hydrolyzed Collagen Peptides Sales Value Share by Type (2021-2032) Figure 20. Food and Beverages Image Figure 21. Pharmaceutical Image Figure 22. Cosmetics Image Figure 23. Personal Care Image Figure 24. Pet Food Image Figure 25. Others Image Figure 26. Global Hydrolyzed Collagen Peptides Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 27. Global Hydrolyzed Collagen Peptides Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Hydrolyzed Collagen Peptides Sales Volume Share by Application (2021-2032) Figure 29. Global Hydrolyzed Collagen Peptides Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Hydrolyzed Collagen Peptides Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Hydrolyzed Collagen Peptides Sales Value Share by Application (2021-2032) Figure 32. Global Hydrolyzed Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 33. Global Hydrolyzed Collagen Peptides Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Hydrolyzed Collagen Peptides Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Hydrolyzed Collagen Peptides Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Hydrolyzed Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 37. North America Hydrolyzed Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Hydrolyzed Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Hydrolyzed Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Hydrolyzed Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Hydrolyzed Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Hydrolyzed Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 43. South America Hydrolyzed Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Hydrolyzed Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Hydrolyzed Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Hydrolyzed Collagen Peptides Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Hydrolyzed Collagen Peptides Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Bone
  • Bovine Hide
  • Fish
  • Pig Skin
  • Others
Applications
  • Food and Beverages
  • Pharmaceutical
  • Cosmetics
  • Personal Care
  • Pet Food
  • Others
Companies covered
  • Rousselot
  • Gelita
  • PB Gelatins
  • Nitta
  • Weishardt
  • Neocell
  • BHN
  • NIPPI
  • Beyond Biopharma
  • Cosen Biochemical
  • Taiaitai
  • SEMNL Biotechnology
  • HDJR
  • HaiJianTang
  • Dongbao
  • Huayan Collagen
  • Mingrang
  • Hailisheng
  • Oriental Ocean
  • CSI BioTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydrolyzed Collagen Peptides Sales Value (2021-2032)
  4. 1.2.2 Global Hydrolyzed Collagen Peptides Sales Volume (2021-2032)
  5. 1.2.3 Global Hydrolyzed Collagen Peptides Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hydrolyzed Collagen Peptides Market Dynamics
  1. 2.1 Hydrolyzed Collagen Peptides Industry Trends
  2. 2.2 Hydrolyzed Collagen Peptides Industry Drivers
  3. 2.3 Hydrolyzed Collagen Peptides Industry Opportunities and Challenges
  4. 2.4 Hydrolyzed Collagen Peptides Industry Restraints
3 Hydrolyzed Collagen Peptides Market by Company
  1. 3.1 Global Hydrolyzed Collagen Peptides Company Revenue Ranking in 2025
  2. 3.2 Global Hydrolyzed Collagen Peptides Revenue by Company (2021-2026)
  3. 3.3 Global Hydrolyzed Collagen Peptides Sales Volume by Company (2021-2026)
  4. 3.4 Global Hydrolyzed Collagen Peptides Average Price by Company (2021-2026)
  5. 3.5 Global Hydrolyzed Collagen Peptides Company Ranking (2024-2026)
  6. 3.6 Global Hydrolyzed Collagen Peptides Company Manufacturing Base and Headquarters
  7. 3.7 Global Hydrolyzed Collagen Peptides Company Product Type and Application
  8. 3.8 Global Hydrolyzed Collagen Peptides Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hydrolyzed Collagen Peptides Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hydrolyzed Collagen Peptides Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hydrolyzed Collagen Peptides Market by Type
  1. 4.1 Hydrolyzed Collagen Peptides Type Introduction
  2. 4.1.1 Bone
  3. 4.1.2 Bovine Hide
  4. 4.1.3 Fish
  5. 4.1.4 Pig Skin
  6. 4.1.5 Others
  7. 4.2 Global Hydrolyzed Collagen Peptides Sales Volume by Type
  8. 4.2.1 Global Hydrolyzed Collagen Peptides Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Hydrolyzed Collagen Peptides Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Hydrolyzed Collagen Peptides Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Hydrolyzed Collagen Peptides Sales Value by Type
  12. 4.3.1 Global Hydrolyzed Collagen Peptides Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Hydrolyzed Collagen Peptides Sales Value by Type (2021-2032)
  14. 4.3.3 Global Hydrolyzed Collagen Peptides Sales Value Share by Type (2021-2032)
5 Hydrolyzed Collagen Peptides Market by Application
  1. 5.1 Hydrolyzed Collagen Peptides Application Introduction
  2. 5.1.1 Food and Beverages
  3. 5.1.2 Pharmaceutical
  4. 5.1.3 Cosmetics
  5. 5.1.4 Personal Care
  6. 5.1.5 Pet Food
  7. 5.1.6 Others
  8. 5.2 Global Hydrolyzed Collagen Peptides Sales Volume by Application
  9. 5.2.1 Global Hydrolyzed Collagen Peptides Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Hydrolyzed Collagen Peptides Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Hydrolyzed Collagen Peptides Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Hydrolyzed Collagen Peptides Sales Value by Application
  13. 5.3.1 Global Hydrolyzed Collagen Peptides Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Hydrolyzed Collagen Peptides Sales Value by Application (2021-2032)
  15. 5.3.3 Global Hydrolyzed Collagen Peptides Sales Value Share by Application (2021-2032)
6 Hydrolyzed Collagen Peptides Regional Sales and Value Analysis
  1. 6.1 Global Hydrolyzed Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydrolyzed Collagen Peptides Sales by Region (2021-2032)
  3. 6.2.1 Global Hydrolyzed Collagen Peptides Sales by Region: 2021-2026
  4. 6.2.2 Global Hydrolyzed Collagen Peptides Sales by Region (2027-2032)
  5. 6.3 Global Hydrolyzed Collagen Peptides Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hydrolyzed Collagen Peptides Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hydrolyzed Collagen Peptides Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hydrolyzed Collagen Peptides Sales Value by Region (2027-2032)
  9. 6.5 Global Hydrolyzed Collagen Peptides Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hydrolyzed Collagen Peptides Sales Value (2021-2032)
  12. 6.6.2 North America Hydrolyzed Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hydrolyzed Collagen Peptides Sales Value (2021-2032)
  15. 6.7.2 Europe Hydrolyzed Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hydrolyzed Collagen Peptides Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hydrolyzed Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hydrolyzed Collagen Peptides Sales Value (2021-2032)
  21. 6.9.2 South America Hydrolyzed Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hydrolyzed Collagen Peptides Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hydrolyzed Collagen Peptides Sales Value Share by Country, 2025 VS 2032
7 Hydrolyzed Collagen Peptides Country-level Sales and Value Analysis
  1. 7.1 Global Hydrolyzed Collagen Peptides Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hydrolyzed Collagen Peptides Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hydrolyzed Collagen Peptides Sales by Country (2021-2032)
  4. 7.3.1 Global Hydrolyzed Collagen Peptides Sales by Country (2021-2026)
  5. 7.3.2 Global Hydrolyzed Collagen Peptides Sales by Country (2027-2032)
  6. 7.4 Global Hydrolyzed Collagen Peptides Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hydrolyzed Collagen Peptides Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hydrolyzed Collagen Peptides Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hydrolyzed Collagen Peptides Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hydrolyzed Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hydrolyzed Collagen Peptides Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Rousselot
  2. 8.1.1 Rousselot Company Information
  3. 8.1.2 Rousselot Business Overview
  4. 8.1.3 Rousselot Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Rousselot Hydrolyzed Collagen Peptides Product Portfolio
  6. 8.1.5 Rousselot Recent Developments
  7. 8.2 Gelita
  8. 8.2.1 Gelita Company Information
  9. 8.2.2 Gelita Business Overview
  10. 8.2.3 Gelita Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Gelita Hydrolyzed Collagen Peptides Product Portfolio
  12. 8.2.5 Gelita Recent Developments
  13. 8.3 PB Gelatins
  14. 8.3.1 PB Gelatins Company Information
  15. 8.3.2 PB Gelatins Business Overview
  16. 8.3.3 PB Gelatins Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 PB Gelatins Hydrolyzed Collagen Peptides Product Portfolio
  18. 8.3.5 PB Gelatins Recent Developments
  19. 8.4 Nitta
  20. 8.4.1 Nitta Company Information
  21. 8.4.2 Nitta Business Overview
  22. 8.4.3 Nitta Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nitta Hydrolyzed Collagen Peptides Product Portfolio
  24. 8.4.5 Nitta Recent Developments
  25. 8.5 Weishardt
  26. 8.5.1 Weishardt Company Information
  27. 8.5.2 Weishardt Business Overview
  28. 8.5.3 Weishardt Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Weishardt Hydrolyzed Collagen Peptides Product Portfolio
  30. 8.5.5 Weishardt Recent Developments
  31. 8.6 Neocell
  32. 8.6.1 Neocell Company Information
  33. 8.6.2 Neocell Business Overview
  34. 8.6.3 Neocell Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Neocell Hydrolyzed Collagen Peptides Product Portfolio
  36. 8.6.5 Neocell Recent Developments
  37. 8.7 BHN
  38. 8.7.1 BHN Company Information
  39. 8.7.2 BHN Business Overview
  40. 8.7.3 BHN Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BHN Hydrolyzed Collagen Peptides Product Portfolio
  42. 8.7.5 BHN Recent Developments
  43. 8.8 NIPPI
  44. 8.8.1 NIPPI Company Information
  45. 8.8.2 NIPPI Business Overview
  46. 8.8.3 NIPPI Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NIPPI Hydrolyzed Collagen Peptides Product Portfolio
  48. 8.8.5 NIPPI Recent Developments
  49. 8.9 Beyond Biopharma
  50. 8.9.1 Beyond Biopharma Company Information
  51. 8.9.2 Beyond Biopharma Business Overview
  52. 8.9.3 Beyond Biopharma Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Beyond Biopharma Hydrolyzed Collagen Peptides Product Portfolio
  54. 8.9.5 Beyond Biopharma Recent Developments
  55. 8.10 Cosen Biochemical
  56. 8.10.1 Cosen Biochemical Company Information
  57. 8.10.2 Cosen Biochemical Business Overview
  58. 8.10.3 Cosen Biochemical Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cosen Biochemical Hydrolyzed Collagen Peptides Product Portfolio
  60. 8.10.5 Cosen Biochemical Recent Developments
  61. 8.11 Taiaitai
  62. 8.11.1 Taiaitai Company Information
  63. 8.11.2 Taiaitai Business Overview
  64. 8.11.3 Taiaitai Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Taiaitai Hydrolyzed Collagen Peptides Product Portfolio
  66. 8.11.5 Taiaitai Recent Developments
  67. 8.12 SEMNL Biotechnology
  68. 8.12.1 SEMNL Biotechnology Company Information
  69. 8.12.2 SEMNL Biotechnology Business Overview
  70. 8.12.3 SEMNL Biotechnology Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 SEMNL Biotechnology Hydrolyzed Collagen Peptides Product Portfolio
  72. 8.12.5 SEMNL Biotechnology Recent Developments
  73. 8.13 HDJR
  74. 8.13.1 HDJR Company Information
  75. 8.13.2 HDJR Business Overview
  76. 8.13.3 HDJR Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 HDJR Hydrolyzed Collagen Peptides Product Portfolio
  78. 8.13.5 HDJR Recent Developments
  79. 8.14 HaiJianTang
  80. 8.14.1 HaiJianTang Company Information
  81. 8.14.2 HaiJianTang Business Overview
  82. 8.14.3 HaiJianTang Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 HaiJianTang Hydrolyzed Collagen Peptides Product Portfolio
  84. 8.14.5 HaiJianTang Recent Developments
  85. 8.15 Dongbao
  86. 8.15.1 Dongbao Company Information
  87. 8.15.2 Dongbao Business Overview
  88. 8.15.3 Dongbao Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dongbao Hydrolyzed Collagen Peptides Product Portfolio
  90. 8.15.5 Dongbao Recent Developments
  91. 8.16 Huayan Collagen
  92. 8.16.1 Huayan Collagen Company Information
  93. 8.16.2 Huayan Collagen Business Overview
  94. 8.16.3 Huayan Collagen Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Huayan Collagen Hydrolyzed Collagen Peptides Product Portfolio
  96. 8.16.5 Huayan Collagen Recent Developments
  97. 8.17 Mingrang
  98. 8.17.1 Mingrang Company Information
  99. 8.17.2 Mingrang Business Overview
  100. 8.17.3 Mingrang Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Mingrang Hydrolyzed Collagen Peptides Product Portfolio
  102. 8.17.5 Mingrang Recent Developments
  103. 8.18 Hailisheng
  104. 8.18.1 Hailisheng Company Information
  105. 8.18.2 Hailisheng Business Overview
  106. 8.18.3 Hailisheng Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Hailisheng Hydrolyzed Collagen Peptides Product Portfolio
  108. 8.18.5 Hailisheng Recent Developments
  109. 8.19 Oriental Ocean
  110. 8.19.1 Oriental Ocean Company Information
  111. 8.19.2 Oriental Ocean Business Overview
  112. 8.19.3 Oriental Ocean Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Oriental Ocean Hydrolyzed Collagen Peptides Product Portfolio
  114. 8.19.5 Oriental Ocean Recent Developments
  115. 8.20 CSI BioTech
  116. 8.20.1 CSI BioTech Company Information
  117. 8.20.2 CSI BioTech Business Overview
  118. 8.20.3 CSI BioTech Hydrolyzed Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 CSI BioTech Hydrolyzed Collagen Peptides Product Portfolio
  120. 8.20.5 CSI BioTech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydrolyzed Collagen Peptides Value Chain Analysis
  2. 9.1.1 Hydrolyzed Collagen Peptides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydrolyzed Collagen Peptides Sales Mode & Process
  6. 9.2 Hydrolyzed Collagen Peptides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydrolyzed Collagen Peptides Distributors
  9. 9.2.3 Hydrolyzed Collagen Peptides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst